Nuwellis (NUWE) Cash from Financing Activities (2011 - 2026)
Nuwellis (NUWE) reported Cash from Financing Activities of $4.4 million for Q1 2026, up 317.78% quarter-over-quarter from $1.1 million in Q4 2025.
Nuwellis (NUWE) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Nuwellis has reported Cash from Financing Activities for 16 years, with the latest figure at $4.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities changed N/A year-over-year to $4.4 million; the trailing twelve-month figure through Mar 2026 stood at $11.3 million (up 8.34% YoY), and the FY2025 full-year result was $6.9 million, down 36.69% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $4.4 million, up from $1.1 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $9.5 million in Q4 2022, with the low at -$20000.0 in Q3 2023.
- Historically, Cash from Financing Activities has averaged $2.2 million across 5 years, with a median of $1.7 million in 2023.
- The largest YoY upside for Cash from Financing Activities was 189120.0% in 2022 against a maximum downside of 100.17% in 2022.
- Nuwellis' Cash from Financing Activities stood at $9.5 million in 2022, then plunged by 83.12% to $1.6 million in 2023, then soared by 195.67% to $4.7 million in 2024, then plunged by 77.69% to $1.1 million in 2025, then jumped by 317.78% to $4.4 million in 2026.
- The last three Cash from Financing Activities figures came in at $4.4 million (Q1 2026), $1.1 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Nuwellis | 279,710.00 | -1.80 Mn | 1.68 Mn | 4.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.40 Mn |
| Mar 31, 2026 | 4.40 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Dec 31, 2024 | 4.72 Mn |
| Dec 31, 2024 | 4.72 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |